-
-
-
-
-
-
-
Goldman Sachs Starts Iovanace Biotherapeutics (IOVA) at Buy
-
-
-
-
-
-
-
Iovance Biotherapeutics Announces First Patient Randomized in Phase 3 TILVANCE-301 Trial in Frontline Advanced Melanoma
-
-
-
15,923 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


